HPV基因的进化分析

目的:HPV有许多类型,其大致可分为高危型和低危型,高危型HPV感染是导致宫颈癌发生的首要原因,在HPV基因组中,E6基因是促进宫颈细胞癌变的关键基因,本文主要研究HPV中的E6基因在各种不同型别的HPV中的进化关系,并对E2基因碱基替换率进行分析,探讨高危型HPV与低危型HPV的区别.方法:本文对不同类型HPV E6氨基酸序列构建系统发生树,探讨识别高危型HPV可能的一致序列,对E6基因其中一处能导致恶性程度增加的突变进行分析.并对HPV16与其位于同一颗树的HPV35和HPV31计算相对碱基替换率.结果:高危型HPV均源自同一株病毒株的进化.各种HPV型别中,高危型HPV E6蛋白对应于HPV16E6蛋白的第83位氨基酸为缬氨酸更为保守,HPV中除E2以外的其他基因的非同义替换率均小于同义替换率.结论:HPV E6蛋白对应于HPV16E6蛋白的第83位氨基酸为缬氨酸能更好地实现HPV E6蛋白的致癌作用.HPV基因中除E2以外的基因在进化过程中都较为保守,是HPV增殖生长的关键基因,而E2部分区域非同义替换率大于同义替换率,说明E2这部分区域的突变能够更好的促进HPV的增殖和生长.     

中国湖北地区HPV16型E6和E7基因变异和进化发生学研究

研究中国湖北地区宫颈癌患者的人乳头瘤病毒16型E6和E7的变异以及HPV16变异体的分布。从宫颈癌患者手术切除标本提取组织DNA,用HPV16 E6和E7特异性引物进行PCR扩增,对扩增的部分E6和E7产物片段进行测序分析。在80例宫颈癌组织DNA中有41例发生E6基因178位核苷酸的突变,突变频率58.75%,相应核苷酸改变为Asp-Glu,E7 647在31例测序样品中有22例发生核苷酸序列A到G改变,使29位氨基酸由Asn变为Ser,突变频率70.97%,结果显示在E6和E7基因的178位和647位核苷酸存在高频率的碱基变异。对E6和E7基因的进化树分析表明,中国湖北地区流行的HPV16病毒株主要为亚洲型变异体(As),其次为欧洲型(E),没有发现非洲-1型(Af-1),非洲-2型(Af-2)和亚洲美洲型(AA)HPV16变异体,中国湖北地区流行的As变异体是否有更高的致宫颈癌的风险还有待于进一步对不同阶段CIN和正常宫颈上皮样品的E6和E7基因进行序列分析和对变异体蛋白进行功能研究。     

特超强毒型马立克病病毒囊膜糖蛋白I基因序列及与其它致病型毒株的比较

特超强毒型 6 48A株马立克病病毒 (MDV)的囊膜糖蛋白I(gI)基因经PCR扩增后克隆进pUC18质粒载体 ,并对其ORF完成了DNA测序。与已发表的其它致病型毒株的糖蛋白I的DNA和氨基酸序列比较表明 ,6 48A株的 gI基因序列与超强毒RBIB株已发表的ORF 5′端 76 1个碱基完全相同。但是在该基因中完整ORF的 10 6 8个碱基中 ,6 48A株与强毒GA株间有 8个碱基变异并导致 7个氨基酸的变化 ,且这一变化主要发生在该基因的 5′端 ,其 3′端三分之一完全相同     

我国登革3型病毒广西80-2株基因组全序列分析

对我国登革 3型病毒 80 2株基因组进行全序列测定 ,为了解其基因组结构与功能的关系提供依据 .根据登革 3型病毒H87株的序列设计并合成引物 ,应用RT PCR和RACE法 ,对 80 2株基因组RNA进行扩增、克隆测序后获得我国登革 3型病毒广西株基因组序列 .该株病毒基因组全长10 696nt ,不含poly(A)尾 ,4种碱基数分别为A :3 4 3 7,C :2 2 15,G :2 773 ,U :2 2 71.包含一个读码框架 ,自 95至 10 2 67位 ,共 10 170个碱基 ,编码 3 3 90个氨基酸 ,5′和 3′非编码区长度分别为 94nt和4 3 2nt.与H 87株比较 ,核苷酸和氨基酸序列同源性均在 99%以上 ,有 2 8个碱基发生改变 ,其中 2 6个碱基突变发生在读码框架内 ,碱基转换 18个 ,颠换 10个 ;碱基突变引起 14个氨基酸的改变 .80 2株与H87株病毒的基因组全序列同源性高 ,变异度小 .     

特超强毒型马立克病病毒囊膜糖蛋白I基因序列及与其它致病型毒株的比较

特超强毒型648A株马立克病病毒(MDV)的囊膜糖蛋白I(gI)基因经PCR扩增后克隆进pUC18质粒载体,并对其ORF完成了DNA测序.与已发表的其它致病型毒株的糖蛋白I的DNA和氨基酸序列比较表明,648A株的gI基因序列与超强毒RBIB株已发表的ORF 5'端761个碱基完全相同.但是在该基因中完整ORF的1068个碱基中,648A株与强毒GA株间有8个碱基变异并导致7个氨基酸的变化,且这一变化主要发生在该基因的5'端,其3'端三分之一完全相同.     

急性弛缓性麻痹病例中Ⅱ型脊髓灰质炎疫苗病毒变异株基因特征分析

研究Ⅱ型脊髓灰质炎(脊灰)疫苗变异株的基因特征,为我国使用口服脊灰减毒活疫苗/脊灰灭活疫苗使用策略,维持无脊灰状态和全球最终消灭脊灰提供科学依据。根据型内鉴定的检测结果,从2000~2001年AFP病例分离到的Ⅱ型脊灰疫苗变异株中选取有聚集性的5株病毒进行全基因组序列测定(贵州省3株、山东省2株),并进行核苷酸、氨基酸同源性分析。贵州省3株病毒全基因组序列完全一致,但与SabinⅢ型病毒发生重组,重组区域在3A区(nt5343~5353);与疫苗株相比,Ⅱ型区域变异10个碱基,其中VP1区变异4个,与SabinⅡ型株核苷酸同源性为99·56%,氨基酸同源性99·34%;Ⅲ型区域变异9个碱基。山东省2株病毒全基因序列共享16个突变位点,没有发生重组,与SabinⅡ型株相比,VP1区分别变异7个和4个碱基,核苷酸同源性分别为99·22%和99·56%,氨基酸同源性分别为99·0%和99·67%。上述5株病毒在重要的减毒位点nt481、nt2909均发生突变。此研究中5株病毒分属于两个不同的传播链,但是共享nt481、nt2909、nt2992三个突变位点,这3个突变位点不在重组区域内,他们的共同作用可能是影响病毒传播力的重要因素,但目前尚无证据证明脊灰疫苗病毒型间重组会增加病毒的毒力及传播力。     

乙脑病毒持续感染株preM区序列分析

为了研究乙型脑炎病毒持续感染株preM区域基因序列变异及其意义,我们将两种乙脑病毒野生株(JaGAr-01株和Nakayama株)分别感染人肝癌KN73细胞,经过多次细胞传代后建立乙脑病毒持续感染模型,收集感染细胞经反复冻融获取变异病毒.利用preM区特异引物进行RT-PCR法得到两种病毒的preM区基因片段,应用基因测序反应进行序列分析,并对两种病毒株preM区序列进行比较.preM区基因测序结果显示,与JaGAr-01野生株比较,JaGAr-01持续感染变异株(JaG-per)有1个核苷酸上碱基发生变异(第26位U→G)并导致相应氨基酸发生置换(第9位亮氨酸→精氨酸);Nakayama持续感染变异株(Nak-per)与其野生株相比则有11个核苷酸上碱基存在差异(第26位U→G,第37位G→A,第39位C→U,第45位U→C,第51位U→C,第99位U→C,第126位U→C,第165位C→U,第189位C→U,第195位C→U,第198位U→C),但仅有其中第26位、第37位、第39位的碱基变异引起相应编码的氨基酸发生置换(第9位亮氨酸→精氨酸及第13位缬氨酸→异亮氨酸).对比还发现变异后的JaGAr-01持续感染株与Nakayama持续感染株的基因序列相同.认为乙脑病毒持续感染变异株preM区存在基因变异,这种变异可能与该区参与病毒持续感染及维持病毒生物学特性有关.     

棕背伯劳羽色多态与MC1R基因的相关性

黑素皮质素受体1 (melanocortin-1 receptor, MC1R)基因是控制动物黑色素合成的重要基因, 鸟类羽色的变异与MC1R基因的变异有密切关系。棕背伯劳(Lanius schach)在我国东部沿海多地存在羽色多态现象, 有棕色型、黑色型和黑色白边型的分化。为了探究MC1R基因与棕背伯劳色型分化的关系, 本研究对分布于广东省的3种色型共计11只棕背伯劳的MC1R基因编码区进行单核苷酸多态性(SNPs)分析和氨基酸多态性分析。结果表明: (1) 11个实验个体的MC1R基因序列共有4种单倍型, 其中黑色型和黑色白边型共享单倍型H3。(2) 3种色型棕背伯劳MC1R基因编码区的第34-931位的899个碱基中共有47个碱基变异位点, 相对应的氨基酸序列共有18个变异位点, 这些变异位点与黑色表型无对应关系。(3)黑色型与黑色白边型个体基因型在第268-303位编码区出现了36个碱基的缺失, 对应着12个氨基酸的缺失, 该缺失与黑色表型相对应。因此推测棕背伯劳的黑化与MC1R基因碱基片段的缺失密切相关。     

小型猪与梅山猪Prop1基因的比较分析

Prop1是一种新发现的参与早期胚胎垂体发育的特异性转录因子。在人和动物均已发现由于该基因突变而引起的综合性垂体功能障碍,进而影响生长和繁殖。小型猪与梅山猪比较,其繁殖力和生长性能差异显著,为了了解这些差异的遗传基础,本试验对五指山猪、藏猪和版纳猪三种小型猪的Prop1基因进行克隆测序,并与已知梅山猪的序列进行对比,结果为:五指山猪与藏猪外显子1第69位发生G-A碱基替换,编码同义氨基酸;藏猪外显子2第115位发生A-G碱基替换,编码终止密码子;藏猪与版纳猪外显子3第466位和第631位均发生C-T碱基替换,第466位藏猪编码同义氨基酸;第631位版纳猪编码丝氨酸(TCC),梅山猪编码脯氨酸(CCC),即两种猪的Prop1基因产物不同。在Prop1基因终止密码下游250左右有一个腺苷酸丰富区,五指山猪与藏猪有15个腺苷酸串联,版纳猪有12个。上述结果为进一步研究大猪和小型猪之间生产性能差异的遗传基础提供了新线索。     

云南省人乳头状瘤病毒16型E6/E7基因的变异分析

研究人乳头状瘤病毒16型E6和E7基因在云南省的变异情况。采集获得2 000例妇科门诊样品,提取DNA,以MY09/MY11为外引物,GP5+/GP6+为内引物,采用nest-PCR法对样品HPV-DNA高变区L1区的相应基因进行扩增、测序和分型,筛选得到20例HPV-16型病毒DNA,对其进行E6和E7基因特异性扩增,测序。结果显示20例HPV-16型E6基因中有10例在178位核苷酸发生碱基突变,突变频率为50%,E7基因中有10例在647位核苷酸发生碱基突变,突变频率为50%。进化树分析结果表明在云南省流行的HPV-16型中主要为亚洲变异型,没有发现非洲1型,非洲2型。     

Reversed-phase high-performance liquid chromatographic assay method for quantitating 6-mercaptopurine and its methylated and non-methylated metabolites in a single sample

Methods of assaying 6-mercaptopurine (6MP) and its methylated and non-methylated metabolites are essential for the therapeutic dose in treating patients with acute lymphoblastic leukemia. However, previous methods are technically complicated and unsuitable for clinical use. Thus, we have now developed a method utilizing reversed-phase high-performance liquid chromatography (HPLC) in order to quantify these compounds in human red blood cells (RBCs) in a single sample to serve as an index of cytotoxic activity. The agents 6MP, 6-thioguanine (6TG) and 6-methylmercaptopurine (6MMP) were well separated by this assay. Linear relationships were observed between the peak areas and the RBC concentrations of 6MP, 6TG and 6MMP over the range of 20–2000, 18–1800 and 18–1800 pmol per 25 mg hemoglobin (Hb), respectively. The limit of quantitation of the assay is 20, 18 and 18 pmol per 25 mg Hb, respectively. This assay system is suitable for routine clinical use.     

Metabolic consequences of drug-induced inhibition of the pentose phosphate pathway in neuroblastoma and glioma cells.

6-Aminonicotinamide leads to a considerable accumulation of 6-phosphogluconate, which is 3 times higher in C-6 glial cells than it is in C-1300 neuroblastoma cells. Dephosphorylation of the accumulated 6-phosphogluconate causes a rise of intracellular gluconate, which can be released from the cells. The higher dephosphorylating capacity of neuroblastoma cells leads to an intracellular gluconate content which is 4 times that found in C-6 glial cells. Although 6-phosphogluconate is a potent competitive inhibitor of glucose phosphate isomerase, no reduction of glycolytic flux and ATP content in stationary phase neuroblastoma cells was found in contrast to observations in C-6 glial cells. Morphological changes are only found in C-6 glial cells during the experimental period.     

白细胞介素6构象研究进展

简要介绍了人白细胞介素6(hIL-6)的一级结构和高级结构;通过对hIL-6突变体的研究,发现hIL-6分子上存在2个活性位点(位点Ⅰ和位点Ⅱ),其中位点Ⅰ识别hIL-6受体(hIL-6R)的分子量为80×10~3的配基结合亚单位,位点Ⅱ与gp130结合参与信号转导,这使得合理设计hIL-6拮抗剂成为可能。     

Micromolar HgCl2 concentrations transitorily duplicate the ATP level in Saccharomyces cerevisiae cells

Low concentrations of HgCl2 elicited, in Saccharomyces cerevisiae, a transitory increase in the ATP level followed by a decrease of its concentration, until almost disappearance. At 1 microM HgCl2, the increase in ATP lasted for about 30 min, while at 10 microM the increase was only observed in the first 5 min of treatment. The initial burst of ATP was accompanied by a decrease in the level of hexose phosphates, whereas during the decrease of ATP an increase in the inosine and hexose phosphates levels took place. The treatment with HgCl2 inhibited the plasma membrane proton ATPase but not the activities of hexokinase or 6-phosphofructokinase.     

6-O-取代红霉素衍生物的研究进展

大环内酯类抗生素广泛用于治疗呼吸道感染,但日益泛滥的大环内酯耐药菌正影响着公众的健康。为了解决这一问题,科研工作者 对大环内酯类化合物进行了大量的结构修饰。综述近年来对红霉素衍生物C6位进行的结构改造及对其生物活性的影响。     

Facile synthesis of 6-amino-6-deoxycellulose

6-Amino-6-deoxycellulose (4) was synthesized from cellulose by three reaction steps, namely bromination at C-6, displacement of bromine by azide ion, and reduction of the azide group to amino group, in 67% overall yield. The 13C NMR spectrum of compound 4 supports the expected structure for 6-amino-6-deoxycellulose. The degree of substitution of compound 4 was 0.96.     

Apparent Absence of a Translocase in the Cerebral Glucose-6-Phosphatase System

In the hepatocyte endoplasmic reticulum, a substrate transporter could provide a means of regulating hydrolysis of glucose-6-phosphate by specifically modulating access of the substrate to the hydrolase. Several characteristics of the cerebral microsomal enzyme suggest that such an hypothesis is untenable in the brain. These are: (a) the inability of the enzyme in either untreated or detergent-disrupted brain microsomes to distinguish between glucose-6-phosphate and mannose-6-phosphate; (b) the close agreement of the apparent Km values for either substrate in intact or disrupted microsomal preparations; (c) the constancy of the latency toward both substrates over a wide concentration range; (d) the inability of nonpenetrating, covalently-linking reagents [e.g., 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS)] to affect the accessibility of the hydrolase to its substrate; (e) the absence of a putative transporter polypeptide, such as that of the liver, in experiments where tritiated H2DIDS, polyacrylamide gel electrophoresis, and radioautography are applied to brain microsomes.     

Structural analysis of human glutamine:fructose-6-phosphate amidotransferase, a key regulator in type 2 diabetes

Glutamine:fructose-6-phosphate amidotransferase (GFAT) is a rate-limiting enzyme in the hexoamine biosynthetic pathway and plays an important role in type 2 diabetes. We now report the first structures of the isomerase domain of the human GFAT in the presence of cyclic glucose-6-phosphate and linear glucosamine-6-phosphate. The C-terminal tail including the active site displays a rigid conformation, similar to the corresponding Escherichia coli enzyme. The diversity of the CF helix near the active site suggests the helix is a major target for drug design. Our study provides insights into the development of therapeutic drugs for type 2 diabetes.     

Quantification of 6-deoxy-6-demethyl-4-dedimethylaminotetracycline (COL-3) in human plasma using liquid chromatography coupled with electrospray ionization tandem mass spectrometry

An accurate and reliable liquid chromatographic-tandem mass spectrometric (LC-MS-MS) method has been developed and validated for the determination of 6-deoxy-6-demethyl-4-dedimethylaminotetracycline (COL-3) in human plasma. The assay used chrysin as an internal standard (I.S.). The analyte and the I.S. were extracted from acidified plasma by methyl-t-butyl ether. Separation was achieved on a YMCbasic column using acetonitrile-water-formic acid mobile phase. The MS-MS detection was by monitoring fragmentation 372.1-->326.2 (m/z) for COL-3 and 255.1-->153.1 (m/z) for the I.S. on a Sciex API 365 using a Turbo Ionspray in positive ion mode. The retention times were approximately 1.7 min for COL-3 and 1.8 min for the I.S. The validated dynamic range was 0.03-10.0 microg/ml using 0.25-ml plasma with correlation coefficients of >or=0.9985. The precision and accuracy for the calibration standards (n=3) were RSD相似文献   

The application of microwave heating to the synthesis of 6-amino-6-deoxycellulose

Microwave heating was applied to the reactions involved in the synthesis of 6-amino-6-deoxycellulose, 4. These included, cellulose solubilization, bromination at C-6, displacement of bromine with azide ion, and reduction of the azido group to an amino group. Compared to conventional heating, this approach had the advantages of shortening reaction times and retaining the degree of polymerization of 4.